Who is sponsoring NCT00194896?

NCT00194896 is sponsored by University of Washington.

What condition does NCT00194896 study?

NCT00194896 studies Type 2 Diabetes Mellitus.

What drugs are being tested in NCT00194896?

Interventions: rosiglitazone, glyburide.

What is the status of NCT00194896?

NCT00194896 is currently COMPLETED.

Last reviewed 2018-03-27 · How we verify

Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes

NCT00194896 NA COMPLETED Results posted

The purpose of this research was to test whether one treatment was superior over another in the management of type 1.5 diabetes. Specifically we tested recently diagnosed antibody positive type 2 diabetic patients to determine whether treatment with rosiglitazone results in greater preservation of beta cell function compared to treatment with glyburide.

Details

Lead sponsor	University of Washington
Phase	NA
Status	COMPLETED
Enrolment	64
Start date	2000-02
Completion	2008-12

Conditions

Type 2 Diabetes Mellitus

Interventions

rosiglitazone
glyburide

Primary outcomes

Changes in Beta Cell Function Assessed by Fasting and Stimulated C-peptide Measured at 36 Months. — 36 months
Changes in beta cell function assessed by fasting and stimulated C-peptide measured at 36 months.

Countries

United States